In the Union Budget 2024-25, the Finance Minister announced the exemption of three additional cancer drugs from customs duties. This initiative aims to reduce the cost of essential cancer treatments, making them more accessible for patients. The exemption is expected to ease the financial strain on individuals battling cancer and reflects the government’s commitment to strengthening healthcare affordability and support for those in need.
